Smith & Nephew Says Catalystem Primary Hip System Got FDA's Premarket Clearance-February 2024-www.financetom.com

Smith & Nephew Says Catalystem Primary Hip System Got FDA's Premarket Clearance

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Smith & Nephew Says Catalystem Primary Hip System Got FDA's Premarket Clearance

Jul 16, 2024 5:59 AM

08:36 AM EDT, 07/16/2024 (MT Newswires) -- Smith & Nephew ( SNN ) said Tuesday its new hip surgery apparatus has received the 510(k) clearance for medical devices from the US Food and Drug Administration.

The clearance is a premarket submission for the company's Catalystem Primary Hip System, paving the way for its introduction to the market.

Price: 27.52, Change: -0.19, Percent Change: -0.69

Previous page： Sandstorm Gold Royalties Renews Normal Course Issuer Bid and Automatic Share Purchase Plan Next page： Valneva Files $350 Million Shelf

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sandstorm Gold Royalties Renews Normal Course Issuer Bid and Automatic Share Purchase Plan

Mar 25, 2025

09:00 AM EDT, 03/25/2025 (MT Newswires) -- Sandstorm Gold ( SAND ) on Tuesday said it has renewed its normal course issuer bid (NCIB) after voluntarily terminated its previous one. Under the new NCIB, which starts on March 27, Sandstorm may buy back up to 20 million shares over the course of a year. Sandstrom has also renewed its automatic...

Valneva Files $350 Million Shelf

Mar 25, 2025

09:03 AM EDT, 03/25/2025 (MT Newswires) -- Valneva (VALN) said Tuesday that it filed a registration statement with the US Securities and Exchange Commission for the potential sale from time to time of up to $350 million of its ordinary shares, American depositary shares and warrants to buy ordinary shares or ADSs. The company intends to use the net proceeds...

Benitec Biopharma Prices $30 Million Equity Offerings

Mar 25, 2025

09:01 AM EDT, 03/25/2025 (MT Newswires) -- Benitec Biopharma ( BNTC ) said Tuesday it has priced an offering of about 1.4 million shares or pre-funded warrants and a concurrent registered direct offering of 900,000 shares of its common stock with long-term investor Suvretta Capital at $13.00 per share and $12.9999 per warrant. The pre-funded warrants will be immediately exercisable,...

Huron Consulting Targets Doubling of Adjusted Earnings Per Share by 2029

Mar 25, 2025

09:02 AM EDT, 03/25/2025 (MT Newswires) -- Huron Consulting ( HURN ) said Tuesday it is targeting to double its adjusted diluted earnings per share by 2029. Huron also said it is aiming for low double-digit annual revenues before reimbursable expenses growth, primarily driven by mid-upper single digit organic growth. ...